Industry | 2015.05.15
Jim Plante, Founder and CEO of Pathway Genomics, Appointed by US Secretary of Commerce and US Trade Secretary to Industry Trade Advisory Committee (ITAC)
SAN DIEGO & WASHINGTON--(BUSINESS WIRE)--Pathway Genomics Corporation, a data-driven global healthcare company and global clinical laboratory, today announced that Founder and CEO Jim Plante has been appointed by the U.S. Secretary of Commerce, Penny Pritzker, and U.S. Trade Representative (USTR), Ambassador Michael Froman to the Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health and Science Products (ITAC 3). Click to Tweet ITAC advisors provide industry expertise in devel
For more information, please visit
http://www.businesswire.com/news/home/20[...]CEO-Pathway-Genomics-Appointed
